SCHEMBL25508085

SCHEMBL25508085

N#COc1c2c(c(F)c3c1CC3)CCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27094884 0.77 — —
SCHEMBL21646764 0.72 NLRP3 (0.30) —
SCHEMBL19869343 0.71 NLRP3 (0.32) —
SCHEMBL21646756 0.63 — —
SCHEMBL22015518 0.62 HAVCR2 (0.30) —
SCHEMBL17042286 0.62 — —
SCHEMBL19475249 0.59 ACHE (0.44) —
SCHEMBL21646536 0.59 HAVCR2 (0.31) —
SCHEMBL19676584 0.59 CA1 (0.30) —
SCHEMBL20681571 0.55 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159555-A1 SULFONIMIDAMIDE COMPOUNDS AS NLRP3 MODULATORS GENENTECH, INC. (US) 2023-05-25 — — US disclosed
US-20230159555-A1 SULFONIMIDAMIDE COMPOUNDS AS NLRP3 MODULATORS GENENTECH, INC. (US) 2023-05-25 — — US disclosed
Send feedback